John Sims, MD
Clinical Cardiac Electrophysiology · Tyler, TXNPI 1801913710
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $194,548 of the $203,826 with a category attached, or 95.4%. Boston Scientific accounts for 93.9% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $63,910, 3.4 times the $18,822 reported in 2019. Among clinical cardiac electrophysiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $575.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$191K
- Johnson & Johnson$8K
- Abbott$2K
- Medtronic$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$168
- Genentech, Inc.$95
- plus $343 from 9 others
What the payments were for
- Consulting fees$3000%
- Speaking & faculty fees$194,54895%
- Travel & lodging$3,0551%
- Food & beverage$5,9243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 254 | $191,464 |
| Johnson & Johnson | 21 | $7,691 |
| Abbott | 23 | $2,210 |
| Medtronic(2 entities) | 25 | $1,854 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $168 |
| Genentech, Inc. | 1 | $95 |
| Biosense Webster, Inc. | 3 | $70 |
| Inspire Medical Systems, Inc. | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Irhythm Technologies, Inc. | 3 | $47 |
| Philips North America LLC | 1 | $23 |
| Atricure, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
| Impulse Dynamics (USA) Inc. | 2 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$60,000
- Rhythmia Mapping System$37,500
- RHYTHMIA$18,750
- XARELTO$7,510
- EMBLEM$7,000
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$4,250
- GENERAL - THERAPIES$3,407
- EMBLEM MRI S-ICD$3,300
- GENERAL BRADY$2,750
- Farapulse$2,380
- AVEIR$1,321
- Micra$671
- AFFERA MAPPING SYSTEM$221
- WATCHMAN Access System$204
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$114
- EnSite Precision Cardiac Mapping System$101
How this compares
$203,826 in reported general payments places this provider in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 405 | $307,324 |
| MultaqDronedarone Hcl | 132 | $115,370 |
| XareltoRivaroxaban | 135 | $103,324 |
| Flecainide Acetate | 279 | $9,032 |
| CorlanorIvabradine Hcl | 16 | $8,837 |
| Metoprolol Succinate | 309 | $5,001 |
| Amiodarone Hcl | 193 | $2,941 |
| Metoprolol Tartrate | 138 | $1,104 |
| Dofetilide | 15 | $933 |
| Carvedilol | 74 | $829 |
| Propafenone Hcl | 21 | $778 |
| Digoxin | 42 | $666 |
| SotalolSotalol Hcl | 34 | $608 |
| Diltiazem Hcl | 32 | $492 |
| Amlodipine Besylate | 19 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCMultaq | $51 | $115,370132 claims |
| Johnson & JohnsonXarelto | $7,691 | $103,324135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Tyler
- Joshua RutlandTyler$168K
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Dale YooMcKinney$585K
- Rodney HortonAustin$553K
- Jose Cuellar SilvaWebster$502K
- Miguel ValderrabanoHouston$461K
- Theodore TakataFort Worth$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.